VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway

Conditions: Cardiovascular Diseases; Insulin Sensitivity/Resistance; Metabolic Disease; Metabolism; Energy Expenditure; Obesity Interventions: Drug: Vericiguat 10 MG; Other: Placebo; Other: Insulin Sensitivity Test; Other: Resting Energy and Exercise Energy Expenditure Assessment; Other: White Adipose Tissue Biopsy; Other: MRI-PET Scan for Brown Adipose Tissue Volume Assessment Sponsors: University of Alabama at Birmingham Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials